EP2076281A4 - Stabilisierende alkylglykosid-zusammensetzungen und ihre verfahren - Google Patents

Stabilisierende alkylglykosid-zusammensetzungen und ihre verfahren

Info

Publication number
EP2076281A4
EP2076281A4 EP06785482A EP06785482A EP2076281A4 EP 2076281 A4 EP2076281 A4 EP 2076281A4 EP 06785482 A EP06785482 A EP 06785482A EP 06785482 A EP06785482 A EP 06785482A EP 2076281 A4 EP2076281 A4 EP 2076281A4
Authority
EP
European Patent Office
Prior art keywords
methods
stabilizing
alkylglycoside compositions
compositions
stabilizing alkylglycoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06785482A
Other languages
English (en)
French (fr)
Other versions
EP2076281A1 (de
Inventor
Edward T Maggio
Michael R Ruff
Candace B Pert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aegis Therapeutics LLC
Original Assignee
Aegis Therapeutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aegis Therapeutics LLC filed Critical Aegis Therapeutics LLC
Priority to EP09161107A priority Critical patent/EP2158920A1/de
Priority to EP09162179A priority patent/EP2158898A1/de
Priority to EP12165052.7A priority patent/EP2505189B1/de
Publication of EP2076281A1 publication Critical patent/EP2076281A1/de
Publication of EP2076281A4 publication Critical patent/EP2076281A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
EP06785482A 2006-06-23 2006-06-23 Stabilisierende alkylglykosid-zusammensetzungen und ihre verfahren Withdrawn EP2076281A4 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP09161107A EP2158920A1 (de) 2006-06-23 2006-06-23 Stabilisierung von Alkylglykosidzusammensetzungen und zugehörige Verfahren
EP09162179A EP2158898A1 (de) 2006-06-23 2006-06-23 Stabilisierung von Alkylglykosidzusammensetzungen und zugehöriges Verfahren
EP12165052.7A EP2505189B1 (de) 2006-06-23 2006-06-23 Stabilisierung von Alkylglykosidzusammensetzungen und zugehöriges Verfahren

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/024577 WO2007149096A1 (en) 2006-06-23 2006-06-23 Stabilizing alkylglycoside compositions and methods thereof

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP12165052.7A Division EP2505189B1 (de) 2006-06-23 2006-06-23 Stabilisierung von Alkylglykosidzusammensetzungen und zugehöriges Verfahren
EP09161107.9 Division-Into 2009-05-26

Publications (2)

Publication Number Publication Date
EP2076281A1 EP2076281A1 (de) 2009-07-08
EP2076281A4 true EP2076281A4 (de) 2010-03-03

Family

ID=38833712

Family Applications (4)

Application Number Title Priority Date Filing Date
EP06785482A Withdrawn EP2076281A4 (de) 2006-06-23 2006-06-23 Stabilisierende alkylglykosid-zusammensetzungen und ihre verfahren
EP09161107A Withdrawn EP2158920A1 (de) 2006-06-23 2006-06-23 Stabilisierung von Alkylglykosidzusammensetzungen und zugehörige Verfahren
EP12165052.7A Active EP2505189B1 (de) 2006-06-23 2006-06-23 Stabilisierung von Alkylglykosidzusammensetzungen und zugehöriges Verfahren
EP09162179A Withdrawn EP2158898A1 (de) 2006-06-23 2006-06-23 Stabilisierung von Alkylglykosidzusammensetzungen und zugehöriges Verfahren

Family Applications After (3)

Application Number Title Priority Date Filing Date
EP09161107A Withdrawn EP2158920A1 (de) 2006-06-23 2006-06-23 Stabilisierung von Alkylglykosidzusammensetzungen und zugehörige Verfahren
EP12165052.7A Active EP2505189B1 (de) 2006-06-23 2006-06-23 Stabilisierung von Alkylglykosidzusammensetzungen und zugehöriges Verfahren
EP09162179A Withdrawn EP2158898A1 (de) 2006-06-23 2006-06-23 Stabilisierung von Alkylglykosidzusammensetzungen und zugehöriges Verfahren

Country Status (3)

Country Link
EP (4) EP2076281A4 (de)
CA (2) CA2743725A1 (de)
WO (1) WO2007149096A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7598343B1 (en) 2008-07-27 2009-10-06 The Medicines Company Pharmaceutical formulations of bivalirudin and processes of making the same
US7582727B1 (en) 2008-07-27 2009-09-01 The Medicinces Company Pharmaceutical formulations of bivalirudin and processes of making the same
US20120035103A1 (en) * 2010-01-29 2012-02-09 Pillion Dennis J Method for administration of insulin and pharmaceutical composition thereof
WO2011139838A2 (en) * 2010-04-28 2011-11-10 Zelos Therapeutics, Inc. Intranasal formulations
CA2802756C (en) 2010-06-24 2021-05-04 Genentech, Inc. Compositions and methods for stabilizing protein-containing formulations
GB201607918D0 (en) 2016-05-06 2016-06-22 Arecor Ltd Novel formulations
WO2018060736A1 (en) * 2016-09-29 2018-04-05 Arecor Limited Novel formulations
CN115015533A (zh) * 2022-05-31 2022-09-06 江西英大生物技术有限公司 一种氧化低密度脂蛋白测定试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3219656A (en) 1963-08-12 1965-11-23 Rohm & Haas Alkylpolyalkoxyalkyl glucosides and process of preparation therefor
US3839318A (en) 1970-09-27 1974-10-01 Rohm & Haas Process for preparation of alkyl glucosides and alkyl oligosaccharides
DK149776C (da) 1984-01-06 1987-04-21 Orion Yhtymae Oy Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
AT382381B (de) 1984-10-02 1987-02-25 Oesterr Zuckerfab Evidenz Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5661130A (en) 1993-06-24 1997-08-26 The Uab Research Foundation Absorption enhancers for drug administration
EP1789075A4 (de) * 2004-08-25 2009-07-01 Uab Research Foundation Absorptionsverbesserer für die arzneimittelverabreichung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ROCCATANO DANILO ET AL: "Mechanism by which 2,2,2-trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: a molecular dynamics study.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 17 SEP 2002, vol. 99, no. 19, 17 September 2002 (2002-09-17), pages 12179 - 12184, XP002563234, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
EP2076281A1 (de) 2009-07-08
EP2505189B1 (de) 2018-08-08
WO2007149096A1 (en) 2007-12-27
EP2158898A1 (de) 2010-03-03
CA2714867A1 (en) 2007-12-27
CA2743725A1 (en) 2007-12-27
EP2158920A1 (de) 2010-03-03
EP2505189A1 (de) 2012-10-03

Similar Documents

Publication Publication Date Title
ZA201001300B (en) Antigen-asjuvant compositions and methods
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
EP1895838A4 (de) Zusammensetzungen und verfahren
HK1137670A1 (en) Compositions and methods for arthrodetic procedures
EP2035014A4 (de) Fucoidan-zusammensetzungen und verfahren
EP2446031A4 (de) Stabilisierung von alkylglykosidzusammensetzungen und verfahren
EP2101731A4 (de) Verfahren und zusammensetzungen mit endoxifen
ZA200808431B (en) Fungicidal compositions and methods of using the same
EP2046936A4 (de) Biozide zusammensetzungen und verfahren
GB0601143D0 (en) Uses, methods and compositions
IL186978A0 (en) Cyclopropene compositions
GB0721291D0 (en) Methods and compositions
EP2088865A4 (de) Guggulphospholipid-verfahren und zusammensetzungen
GB0617171D0 (en) Novel compositions and methods
GB0622399D0 (en) Novel compositions and uses thereof
EP2076281A4 (de) Stabilisierende alkylglykosid-zusammensetzungen und ihre verfahren
EP1848438A4 (de) Diaminophenothiazin-zusammensetzungen und deren verwendung
EP2320739A4 (de) Pharmazeutische zusammensetzungen und verfahren zu ihrer stabilisierung
GB0719526D0 (en) Compositions and methods
EP1998753A4 (de) Zusammensetzungen mit hoher ablagerung und ihre verwendung
EP2247303A4 (de) Hämostase-modulierende zusammensetzungen und ihre verwendungen
GB0715428D0 (en) Compositions and uses thereof
GB0701170D0 (en) Compositions and uses thereof
GB0622400D0 (en) Novel compositions and uses thereof
GB0501348D0 (en) Compositions and methods

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090120

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/28 20060101ALI20100120BHEP

Ipc: A61K 47/26 20060101ALI20100120BHEP

Ipc: A61K 38/29 20060101ALI20100120BHEP

Ipc: A61K 38/27 20060101ALI20100120BHEP

Ipc: A61K 38/21 20060101ALI20100120BHEP

Ipc: A61K 38/18 20060101ALI20100120BHEP

Ipc: A61K 38/08 20060101ALI20100120BHEP

Ipc: A61K 9/19 20060101AFI20100120BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20100129

17Q First examination report despatched

Effective date: 20100413

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130507